Pharmaceuticals Companies By Pe Ratio

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Price To Earning
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Price To EarningEfficiencyMarket RiskExp Return
1AMPH Amphastar P
972.67
(0.01)
 2.55 
(0.03)
2HCM HUTCHMED DRC
335.94
 0.00 
 3.39 
 0.01 
3HRMY Harmony Biosciences Holdings
293.37
 0.00 
 3.95 
 0.00 
4ELAN Elanco Animal Health
241.75
(0.07)
 2.52 
(0.19)
5AMRX Amneal Pharmaceuticals, Class
230.5
(0.01)
 1.78 
(0.03)
6COCP Cocrystal Pharma
193.33
 0.08 
 5.04 
 0.41 
7CLSD Clearside Biomedical
130.0
 0.04 
 5.33 
 0.22 
8AZN AstraZeneca PLC ADR
103.39
(0.24)
 1.52 
(0.36)
9CARA Cara Therapeutic
62.54
(0.01)
 4.38 
(0.06)
10AVDL Avadel Pharmaceuticals PLC
61.46
(0.09)
 4.34 
(0.39)
11LLY Eli Lilly and
54.92
(0.14)
 1.91 
(0.27)
12ACB Aurora Cannabis
46.94
(0.09)
 3.77 
(0.32)
13ZTS Zoetis Inc
43.89
(0.05)
 1.31 
(0.06)
14ANIP ANI Pharmaceuticals
43.35
(0.05)
 2.44 
(0.12)
15RPRX Royalty Pharma Plc
37.7
(0.11)
 1.00 
(0.11)
16NVO Novo Nordisk AS
37.42
(0.20)
 1.80 
(0.37)
17CRON Cronos Group
36.41
(0.02)
 3.12 
(0.07)
18JAZZ Jazz Pharmaceuticals PLC
35.18
 0.10 
 1.95 
 0.19 
19RDY Dr Reddys Laboratories
31.58
(0.16)
 1.28 
(0.21)
20CORT Corcept Therapeutics Incorporated
30.07
 0.31 
 2.81 
 0.87 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit. Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY